UBR5 and bladder transitional cell carcinoma: UBR5 expression was significantly increased in bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), colon adenocarcinoma (COAD), esophageal carcinoma (ESCA), cholangiocarcinoma (CHOL), liver hepatocellular carcinoma (LIHC), Glioblastoma multiforme (GBM), head and neck squamous cell carcinoma (HNSC), lung squamous cell carcinoma (Figure 1).